MiniMed (MMED) Cash from Financing Activities (2025 - 2026)
MiniMed (MMED) posted Cash from Financing Activities of $512.0 million for Q2 2026, up 153.47% quarter-over-quarter from $202.0 million in Q3 2025, and up 2148.0% YoY from $22.8 million in Q2 2025.
Powered by 
Analysis
MiniMed (MMED) Cash from Financing Activities (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Cash from Financing Activities data on file, last reported at $512.0 million in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities rose 2148.0% year-over-year to $512.0 million; the trailing twelve-month figure through Jul 2026 stood at $689.0 million (changed N/A YoY), and the FY2026 full-year result was $716.0 million, up 7060.0% from the prior year.
- Cash from Financing Activities was $512.0 million for Q2 2026 at MiniMed, up from $202.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $512.0 million in Q2 2026 to a low of -$25.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -213.50 Mn |
| 10 | MiniMed | 6.37 Bn | 6.17 Bn | 465.00 Mn | - |